Milk-and-Dairy-Products-in-Human-Nutrition-FAO

Recommendations

Info

Table 7.1 (continued) ASIA AND PACIFIC Country/organization Title (duration) Reference India/Center for Micronutrient Research in India/Johns Hopkins Bloomberg School of Public Health Efficacy of fortified milk on morbidity (2002–2004) Sazawal et al. (2007) Indonesia/Johns Hopkins University Consumption of iron-fortified milk and noodles (1999–2003) Semba et al. (2010) Target population Goal/ objective 1–3 yrs Evaluate efficacy of micronutrient fortified milk on morbidity outcomes (diarrhoea, acute respiratory illness) 6–59 mo Determine the level of risk reduction for anaemia associated with consumption of iron-fortified milk and noodles Intervention: strategy and activities Intervention group: fortified milk with iron (9.6 mg), zinc (7.8 mg), selenium (4.2 µg), copper (0.27 mg), vit A (156 µg), vit C (40.2 mg), and vit E (7.5 mg) *Families participating in Nutritional Surveillance System (NSS) of Ministry of Health and Helen Keller International *Child consumption of milk or noodles in the previous week and commercial brand of product documented *HemoCue used to measure haemoglobin in children Design: comparison groups and methods Randomised, double-blinded controlled trial in peri-urban region of northern India Intervention group: fortified milk for one year (n=316) Control group: non-fortified milk for one year (n=317) Observational study using stratified, multistage cluster sampling to collect survey data over 17 rounds; multiple logistic regression models used to examine determinants (fortified milk and noodles) of child anaemia 4 800 urban households and 1 560 rural households Level of Inference Results Probability *Odds of days with severe illness reduced by 15%, incidence of diarrhoea by 18%, and incidence of acute lower respiratory illness by 26% *Greater benefits observed in younger children (≤24 mo) Plausibility *Children showed significantly lower risk of anaemia associated with consumption of fortified milk in both rural and urban areas, adjusted OR: 0.76; 95% CI: 0.72, 0.80 (P
Table 7.1 (continued) Country/organization Title (duration) Reference Target population Goal/ objective Intervention: strategy and activities Design: comparison groups and methods Level of Inference Results 310 Milk powder and blended foods Ghana/University of Ghana/University of CA-Davis Home fortification of complementary foods (February 2004–June 2005) Adu-Afarwuah et al. (2007) Adu-Afarwuah et al. (2008) 6 mo Compare the impact of different types of micronutrient supplements added to home-prepared CF on growth, micronutrient status, and development outcomes *Infants randomised to receive one of 3 home fortification methods or into control group *Daily dose from 6 to 12 mo *Infants followed weekly for dietary intake and morbidity outcomes *Anthropometry collected at 6, 9, and 12 mo; biomarkers at 6 and 12 mo; motor development at 12 mo Randomised, controlled trial in Koforidua of Ghana; all infants followed longitudinally at 6, 9, and 12 mo Group 1: Sprinkles Group 2: Nutritab Group 3: Nutributter with dry skimmed milk Group 4: control Total (n=313) Probability *Nutributter group had greater WAZ and HAZ than Nutritab and Sprinkles group (P=0.05); no significance difference with control group *Nutributter group showed higher percentage of children walking independently by 12 mo *3 intervention groups showed higher ferritin and lower transferring receptor concentrations than control at 12 mo AFRICA Malawi/Washington University/FANTA Supplemental feeding with fortified spreads 1 (January 2007– February 2008) Matilsky et al. (2009) 6–60 m WHZ between −3 and −2 Investigate whether fortified spreads (FS) (milk and soy) improve recovery rates from moderate wasting compared to corn soy blend (CSB) food aid product 1 Fortified spread here refers to ready to use therapeutic food (RUTF). *Children randomised to receive one of three food products daily until exceeded target weight (.1 kg > WHZ) or until 8 weeks *Assessed every 2 weeks Randomised, clinical effectiveness trial. Children followed biweekly for 8 weeks Group 1: milk powder peanut FS (25% milk; 26% peanut; 49% oil & sugar) Group 2: soy powder peanut FS (26% soy; 27% peanut; 47% oil & sugar) Group 3: corn soy blend (80% corn; 20% soy) *Iron deficiency anaemia lower (10%) in interventions groups compared to control (31%) (P
Page 1 and 2:
MILK dairy products in and human nu
Page 3 and 4:
cover photo credits front: © EADD/
Page 5 and 6:
iv 2.7 Emerging issues and challeng
Page 7 and 8:
vi 5.2 Dairy components 209 5.2.1 M
Page 9 and 10:
viii 9.2 Key trends and emerging is
Page 11 and 12:
x 2.5 Per capita energy intake from
Page 13 and 14:
xii Preface Billions of people arou
Page 15 and 16:
xiv The publication serves a variet
Page 17 and 18:
xvi (Research Assistant Professor,
Page 19 and 20:
xviii Permissions granted by extern
Page 21 and 22:
xx FPCM fat and protein-corrected m
Page 23 and 24:
xxii Contributors Anthony Bennett j
Page 25 and 26:
xxiv from the National University o
Page 27 and 28:
xxvi Award 2010 along with colleagu
Page 29 and 30:
2 Milk and dairy products in human
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 38 and 39:
11 Chapter 2 Milk availability: Cur
Page 40 and 41:
Chapter 2 - Milk availability: Curr
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Table 2.5 Volume and share of milk
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
41 Chapter 3 Milk and dairy product
Page 70 and 71:
Chapter 3 - Milk and dairy product
Page 72 and 73:
Table 3.1 Proximate composition of
Page 74 and 75:
Table 3.2 (continued) Vitamins Ribo
Page 76 and 77:
Table 3.4 Mineral composition in mi
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Table 3.6 (continued) Riboflavin Vi
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
103 Chapter 4 Milk and dairy produc
Page 132 and 133:
Chapter 4 - Milk and dairy products
Page 134 and 135:
Table 4.1 Nutrient content of full
Page 136 and 137:
Table 4.2 Contents of selected nutr
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Table 4.4 Summary of recent review
Page 176 and 177:
Table 4.4 (continued) Reference Die
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Annex Table 4.7 Milk and dairy prod
Page 212 and 213:
Table 4.7 (continued) Region and co
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
207 Chapter 5 Dairy components, pro
Page 236 and 237:
Chapter 5 - Dairy components, produ
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Annex Table 5.2 EU register of dair
Page 264 and 265:
Table 5.2 (continued) Claim type Ar
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
243 Chapter 6 Safety and quality Ma
Page 272 and 273:
Chapter 6 - Safety and quality 245
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287: Chapter 6 - Safety and quality 259
Page 300: Chapter 6 - Safety and quality 273
Page 303 and 304: 276 Milk and dairy products in huma
Page 327 and 328: Table 7.1 (continued) Country/organ
Page 335: Table 7.1 (continued) 308 Country/o
Page 387 and 388:
360 Milk and dairy products in huma
Page 389 and 390:
Page 391 and 392:
Page 393 and 394:
Page 395 and 396:
Page 397 and 398:
Page 399 and 400:
Page 401 and 402:
Page 403 and 404:
show all

Milk-and-Dairy-Products-in-Human-Nutrition-FAO

Create successful ePaper yourself

Delete template?

Save as template?